ACM Biolabs

Singapore, Singapore

ACM Biolabs develops novel vaccines and antibodies using proprietary artificial cell membrane technology.

Sep 2022

Venture - Series Unknown

Top Investors

Ritz Venture Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are ACM Biolabs's investors?

ACM Biolabs's investors include Ritz Venture Capital.

Where is ACM Biolabs headquartered?

ACM Biolabs is headquartered in Singapore, Singapore.

What does ACM Biolabs do?

ACM Biolabs develops novel vaccines and antibodies using proprietary artificial cell membrane technology.

What stage is ACM Biolabs at?

ACM Biolabs is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2022.

MLA

"ACM Biolabs — Funding & Investors." VCBacked, September 22, 2022, https://www.vcbacked.co/company/acm-biolabs. Accessed July 1, 2026.

APA

VCBacked. (2022). ACM Biolabs — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/acm-biolabs

Wikipedia (cite web)

{{cite web |title=ACM Biolabs — Funding & Investors |url=https://www.vcbacked.co/company/acm-biolabs |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2022.